Business ❯ Investing ❯ Pharmaceuticals

Manufacturing

Eli Lilly Job Creation Active Pharmaceutical Ingredients Johnson & Johnson AstraZeneca Supply Chain Vaccine Development Pharmaceutical Facilities Roche Novo Nordisk

Amgen Invests $300 Million to Expand Puerto Rico Biologics Plant

The move signals a push to shore up U.S. drug supply chains under new import‑tariff pressure.

AbbVie to Build $1.4 Billion Injectable-Medicines Campus in Durham, N.C.

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

AbbVie to Invest $380 Million in Two North Chicago API Plants

Johnson & Johnson to Build $1 Billion Cell Therapy Plant in Pennsylvania

Eli Lilly Picks Lehigh Valley for $3.5 Billion Plant to Make Next-Gen Weight-Loss Drugs

Novartis Picks North Carolina for Flagship End-to-End Drug Manufacturing Hub

Merck Breaks Ground on $3 Billion Virginia Plant in $70 Billion U.S. Expansion

AstraZeneca Breaks Ground on $4.5 Billion Virginia Plant With Expanded Cancer and Obesity Drug Production

Eli Lilly to Invest Over $1 Billion in India for Contract Manufacturing, Hyderabad Quality Hub

Eli Lilly Chooses Houston for $6.5 Billion Plant to Produce APIs for Orforglipron and Other Drugs

J&J Commits $2 Billion to 10-Year Fujifilm Deal for North Carolina Biologics Hub

AbbVie to Build $195 Million API Facility in North Chicago

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030

Roche Announces $50 Billion U.S. Investment to Expand Manufacturing and R&D

Johnson & Johnson Launches $55 Billion U.S. Manufacturing and Research Expansion

Eli Lilly to Invest $4.5 Billion in New Indiana Drug Manufacturing Facility